November 12, 2010 | Complete Genomics' IPO this week came in lower than they had expected. Originally predicting $12-$14 per share, the initial prices was $9 per share and stock fell 11% the first day of trading, closing at $8.03. The deal still raised $54 million, though the company was hoping to raise as much as $86 million. Xconomy